| Office of Cancer Genomics

CTD² Data Portal

Last Updated: June 15, 2020

Banner for CTD squared program. Links to CTD squared program page The CTD² Network aims to understand the tumor heterogeneity and drug resistance for the development of efficient strategies to identify optimal combinations of small-molecules or immunotherapy with small molecules. The CTD² Data Portal provides access to raw/analyzed primary data generated from different types of approaches e.g. chemical genetics (small-molecules, natural products); genome-wide gain-of-function (cDNA expression libraries, CRISPRa); genome-wide loss-of-function (siRNA, shRNA, CRISPR/Cas9, CRISPRi); protein-protein interactions; and in vivo gain and loss-of function studies.

There are currently {{row_count}} datasets and can be sorted by Center or the assay type.

Users must use data with discretion and acknowledge the CTD² Network.

{{ctd2nodes.nodes.length}} Centers

{{methods.length}} Methods

{{ project.node.title.title}}

{{project.node.title.title}}

{{project.node.row[0].project_title != NULL ? project.node.row.length : 0}} Datasets

{{method.assay}}

{{method.number}} Datasets

{{row.project_title.title}}

{{row.project_title}}

{{row.dpp.title}}

{{row.dpp.body.length > 200 ? 'Read More...' : ''}}

Data

Access the {{data.data_link.title}}

Experimental Approaches

{{approach.dpp_title}}

{{approach.dpp_body.length > 150 ? 'Read More...' : ''}}

Principal Investigator

{{investigator.investigator}}

Contact Name

{{contact_link.title}}

Reference

{{paper.paper_link.title}}

{{row.dpp_title}}

{{row.dpp_body.length > 200 ? 'Read More...' : ''}}

Data

Access the {{data.data_title}}

Experimental Approaches

{{approach.dpp_title}}

{{approach.dpp_body.length > 150 ? 'Read More...' : ''}}

Principal Investigator

{{investigator.investigator}}

Contact Name

{{contact_link.title}}

Reference

{{paper.paper_title}}